Latest News and Press Releases

New clinical trial supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA for Phase 2 clinical study (nextHERIZON) in HER-2 positive gastric or gastroesophageal junction...

Luxembourg, Luxembourg, March 14, 2022 (GLOBE NEWSWIRE) -- Shootpad is a decentralized Cardano based multi chain IDO platform that generates revenue for $SHOOT users. In a bid to scale the project,...

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023Lecanemab collaboration to continue unchanged...

Cape Coral, FL, March 14, 2022 (GLOBE NEWSWIRE) -- GameFi is the dynamic combination of gaming and decentralised finance. This innovation in the cryptocurrency space has given rise to an array of...

CALGARY, Alberta, March 14, 2022 (GLOBE NEWSWIRE) -- Cardinal Energy Ltd. ("Cardinal" or the "Company") (TSX: CJ) is pleased to announce its operating and financial results for the fourth quarter...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia Therapeutics, Inc. (“Akebia” or the “Company”) (NASDAQ: AKBA) and...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI). Such investors are advised to...

BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts  First clinical data demonstrating effectiveness of HGNS to treat CCC patients As previously disclosed, confirms achievement of...

MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research,...

PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has closed...